UK Innovation and Science Seed Fund (UKI2S) are pleased to host a short seminar on spinning out and raising venture capital. This seminar is primarily aimed at senior academics, but we also actively encourage more junior academics with a keen interest in the commercialisation of research to attend. It will be an interactive session going through some of the major steps to consider before spinning out and successfully raise funds for a spin-out company. Topics covered will include: five things to consider before becoming a founder, and what investors like to see before investing.
Oliver and Hassan will be available for one-to-one office hours throughout the day. These sessions are aimed at academics who may be keen to spin out now and have questions around plans, strategy, term sheets etc, or exploring what a spin out may involve and areas to consider. If you want to sign up for one of the sessions, please contact k.kinkelin@bristol.ac.uk
Hosted by:
- Adam Perriman, Academic Founder
- Andrew Wilson, Senior Research Commercialization Manager, Research and Enterprise Development
- Kerstin Kinkelin, Bristol BioDesign Institute Innovation Manager
Speakers
- Oliver Sexton - Oliver invests from UKI2S, an early stage seed/series A fund that backs companies developing complex science and engineering led solutions to global challenges. Prior to joining UKI2S Oliver managed commercialisation of bioengineering and medical technologies at Imperial Innovations and worked at Ark Therapeutics as well as managing a team of biotech buy-side analysts.
- Hassan Mahmudul - Hassan is responsible for screening new investment opportunities, due diligence for promising opportunities, and portfolio support and monitoring. Prior to joining UKI2S, Hassan developed his interest in startups while working as one of the first employees for a leading start-up. He has also founded a VC backed tech startup.
About UKI2S
The UK Innovation and Science Seed Fund (UKI2S) is a publicly backed venture capital fund committed to nurturing new business arising from the world-class science undertaken in the UK in sectors such as biotechnology, synthetic biology, engineering, agriculture, computer science and environmental technology. Providing long-term, patient capital, the fund has helped build innovative businesses, leverage private investment and grow jobs. Beyond seed funding, UKI2S provides strategic advice and support to companies in their early stages.